JARAMILLO LORANCA, BLANCA ESTELA
BIOLOGÍA Y QUÍMICA · Nivel 1
Desde 2023 es Directora de Area en Universidad Politécnica de Pachuca
Dr. Blanca Estela Jaramillo Loranca is a Mexican researcher and professor specializing in biotechnology, cellular and molecular biology, drug delivery systems, and intellectual property. She currently serves as Director of Research, Innovation and Graduate Studies at Universidad Politécnica de Pachuca....
Dr. Blanca Estela Jaramillo Loranca is a Mexican researcher and professor specializing in biotechnology, cellular and molecular biology, drug delivery systems, and intellectual property. She currently serves as Director of Research, Innovation and Graduate Studies at Universidad Politécnica de Pachuca. Her research focuses on the development of anticancer and antiviral drug carriers and the identification of biomarkers associated with neurodegenerative diseases using biotechnological, cellular, and molecular approaches. She is actively involved in graduate education, scientific research, innovation, and technology transfer.
| Nombre | BLANCA ESTELA JARAMILLO LORANCA |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | BIOLOGÍA Y QUÍMICA |
| Disciplina | OTRAS ESPECIALIDADES DE LA BIOLOGÍA |
| Especialidad | OTRAS |
| CVU | 94649 |
| Institución | |
|---|---|
| Dependencia | BIOTECNOLOGIA |
| Entidad | HIDALGO |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2025 |
| Fin: 31/12/2029 |
Publicaciones ORCID
- 2026
- LAG-3 antagonists for cancer treatment: an updated patent review (2020–2025) Expert Opinion on Therapeutic Patents
- Exploratory Study on Hybrid Systems Performance: A First Approach to Hybrid ML Models in Breast Cancer Classification AI
- 2025
- Vulnerability of the entorhinal cortex II to neurodegeneration in Alzheimer’s disease Brain Communications
- 2024
- Efecto del glutaraldehído en las propiedades viscoelásticas de hidrogeles de carboximetilcelulosa Ingeniería Investigación y Tecnología
- Synthesis and toxicity assessment of Coffea arabica extract-derived gold nanoparticles loaded with doxorubicin in lung cancer cell cultures Frontiers in Bioengineering and Biotechnology
- 2021
- Síntesis, caracterización y aplicaciones de las nanopartículas de oro en tratamientos contra el cáncer. Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo
- 2020
- Study of the intracellular xylanolytic activity of the phytopathogenic fungus Sporisorium reilianum Mycoscience
- 2019
- Effect of the analogue of L-carnitine, β-hydroxyphosphocarnitine on the metabolism of Nocardia brasiliensis ECORFAN Journal-Ecuador
- 2015
- The sigma agonist 1,3-Di-o-tolyl-guanidine reduces the morphological and behavioral changes induced by neonatal ventral hippocampus lesion in rats Synapse
- 2014
- Differential Effect on Two Immobility Responses by Chronic Administration of 1,3-di-o-Tolyl-Guanidine (Sigma Receptor Agonist) in Rats with Neonatal Ventral Hippocampal Lesion Pharmacology & Pharmacy
